Jyoti S Mayadev
NRG Oncology
3
3
2
N/A
0
13
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+7 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ann H Klopp
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Kathleen Schmeler
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Laleh Melstrom
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Allison M Quick, MD
Ohio State University Comprehensive Cancer Center
Shared therapeutic areas:
Allison E. Garda, MD
Mayo Clinic in Rochester
Shared therapeutic areas:
Sharon Manne
Rutgers Cancer Institute of New Jersey
Shared therapeutic areas:
Worked with same sponsors:
Stephanie Lheureux
University Health Network Princess Margaret Cancer Center LAO
Shared therapeutic areas:
Worked with same sponsors:
Ntokozo Ndlovu
Parirenyatwa Hospital
Shared therapeutic areas:
Worked with same sponsors:
Simon Lo
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Peter Rose
Gynecologic Oncology Group
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer
All 3 trials loaded